BEVERLY HILLS, Calif. (AP) _ Capricor Therapeutics Inc. (CAPR) on Thursday reported a loss of $2.1 million in its first quarter.

The Beverly Hills, California-based company said it had a loss of 30 cents per share.

The biotechnology company posted revenue of $185,700 in the period. Its adjusted revenue was $186,000.

Capricor shares have risen fivefold since the beginning of the year. In the final minutes of trading on Thursday, shares hit $6.55, a climb of 60% in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CAPR at https://www.zacks.com/ap/CAPR

Automated Insights, source Associated Press News